Arphra/Issuer/LH

LH

Labcorp Holdings Inc.

HealthcareMedical - Diagnostics & ResearchUSUSD

$257.72

+0.53%LiveJun 01, 2026

AI Brief

Market cap

$21.13B

52w range

241.81 – 293.72

P / E

—

EPS

—

Volume

28.64K

Revenue · FY

$13.95B

+7.25% YoY

Explain this page

Arphra AIPlain-English read on Labcorp Holdings Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$5.44M

10 txns

Net flow

−$5.44M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$254.86

Change

+2.83%

Period high

$290.93

Period low

$243.04

Period start

$247.852025-06-02

Through 2026-05-04

Peers

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-0.90%	-0.88%	+0.73%	-10.86%	-3.74%	+2.72%	+3.98%	+41.21%	+13.75%	+133.92%	+1130.73%

Aftermarket

Live

Jun 01, 06:34 PM

Last trade

$257.71

212 sh

Bid

$257.61

40 sh

Ask

$257.80

12 sh

Spread

$0.190

Sector & industry today

Live

Sectors

Technology
+4.11%
Basic Materials
+1.08%
Energy
+0.87%
Industrials
+0.37%
Consumer Cyclical
+0.34%
Communication Services
+0.08%
Utilities
-0.27%
Real Estate
-0.63%
Consumer Defensive
-0.82%
Financial Services
-1.11%
Healthcare
-1.21%

Top industries (issuer's industry highlighted)

Medical - Diagnostics & Research
+0.16%
Computer Hardware
+7.50%
Software - Infrastructure
+7.00%
Coal
+4.70%
Semiconductors
+4.59%
Luxury Goods
-4.44%
Consulting Services
+4.19%
Staffing & Employment Services
+4.08%
Broadcasting
+3.74%
Copper
+3.51%
Medical - Equipment & Services
+3.50%
Electronic Gaming & Multimedia
-3.39%

Fair value

Football field →

Weighted blend

$500.53

+94.22% vs spot

Recommendation

Strong Buy

18 of 19 methods

Method spread

8bull8bear

±5% threshold

Analyst PT consensus: $311.33 (+20.80%)

Total assets

$18.39B

Total debt

$7.2B

Cash & equiv

$532.3M

Operating CF

$1.64B

Free cash flow

$1.21B

Buybacks

-$450M

Analyst view

DB · price_targets + analyst_grades

Consensus target

$311.33

+20.80% upside

Low

$300.00

Median

$300.00

High

$334.00

Recent actions

0 ↑0 ↓8 hold

May 01, 2026
Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Mar 2026	$3.54B	$277.8M	$3.35
Q4 Dec 2025	$3.52B	$164.7M	$1.98
Q3 Sep 2025	$3.56B	$261.1M	$3.12
Q2 Jun 2025	$3.53B	$237.9M	$2.84
Q1 Mar 2025	$3.35B	$212.8M	$2.52
Q4 Dec 2024	$3.33B	$143.4M	$1.70

Recent insiders

All →

Insider	Action	Shares	Value	Date
Meltzer Jonathan C officer: EVP, Operations	Sell	839	$224.05K	Mar 27, 2026
Wilkinson Peter J officer: SVP, Chief Accounting Officer	Sell	1,633	$436.09K	Mar 27, 2026
Schechter Adam H director, officer: President & CEO	Sell	8,705	$2.44M	Mar 03, 2026
van der Vaart Sandra D officer: EVP, Corporate Affairs	Sell	548	$156K	Feb 27, 2026
Caveney Brian J officer: EVP, Pres of ED, CMO & CSO	Sell	1,500	$429.46K	Feb 24, 2026
Wilkinson Peter J officer: SVP, Chief Accounting Officer	Sell	666	$185.11K	Feb 19, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$13.95B	$1.52B	$876.5M	$10.46	+6.28%
FY 2024	$13.01B	$1.09B	$746M	$8.84	+5.73%
FY 2023	$12.16B	$725.6M	$418M	$4.77	+3.44%
FY 2022	$11.86B	$1.44B	$1.28B	$13.96	+10.78%
FY 2021	$13.14B	$3.05B	$2.38B	$24.38	+18.10%